These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 15199517

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Diagnosis of thrombophilia]].
    Kemkes-Matthes B.
    Zentralbl Chir; 2001 Jun; 126(6):433-7. PubMed ID: 11446062
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities.
    Martinelli I, Battaglioli T, Bucciarelli P, Passamonti SM, Mannucci PM.
    Circulation; 2004 Aug 03; 110(5):566-70. PubMed ID: 15262837
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Natural coagulation inhibitory proteins and activated protein C resistance in Turkish patients with inflammatory bowel disease.
    Payzin B, Adakan FY, Yalçin HC, Cetinkaya GS, Berkmen S, Eraslan S, Unsal B.
    Turk J Gastroenterol; 2006 Sep 03; 17(3):183-90. PubMed ID: 16941251
    [Abstract] [Full Text] [Related]

  • 15. Heterogeneity of activated protein C resistance phenotype in subjects with compound heterozygosity for HR2 haplotype and FV Leiden mutation (R506Q) in factor V gene.
    Castaman G, Ruggeri M, Tosetto A, Rodeghiero F.
    Thromb Haemost; 2000 Aug 03; 84(2):357-8. PubMed ID: 10959717
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Evaluation of thrombotic children with malignancy.
    Unal S, Varan A, Yalçin B, Büyükpamukçu M, Gürgey A.
    Ann Hematol; 2005 Jun 03; 84(6):395-9. PubMed ID: 15735962
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Thrombosis risk in systemic lupus erythematosus: the role of thrombophilic risk factors.
    Sallai KK, Nagy E, Bodó I, Mohl A, Gergely P.
    Scand J Rheumatol; 2007 Jun 03; 36(3):198-205. PubMed ID: 17657674
    [Abstract] [Full Text] [Related]

  • 20. [Venous thromboembolic disease: which coagulation screening, for whom, when?].
    Wautrecht JC.
    Rev Med Brux; 2005 Sep 03; 26(4):S315-9. PubMed ID: 16240880
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.